Detalhe da pesquisa
1.
Pitfalls in the lab assessment of hypopituitarism.
Rev Endocr Metab Disord
; 25(3): 457-465, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609701
2.
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency.
Pituitary
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38819617
3.
Altered Circulating Leptin, hGH, and IGF-I in Prediabetes and Screening-Diagnosed T2DM Unrelated to Metabolic Syndrome in Women Post Gestational Diabetes.
Horm Metab Res
; 54(9): 613-619, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35556239
4.
Differences between immunotherapy-induced and primary hypophysitis-a multicenter retrospective study.
Pituitary
; 25(1): 152-158, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34518996
5.
Comprehensive insights into the formation of metabolites of the ghrelin mimetics capromorelin, macimorelin and tabimorelin as potential markers for doping control purposes.
Biomed Chromatogr
; 35(6): e5075, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33458843
6.
Motivation for and adherence to growth hormone replacement therapy in adults with hypopituitarism: the patients' perspective.
Pituitary
; 23(5): 479-487, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32441023
7.
Biochemical investigations in diagnosis and follow up of acromegaly.
Pituitary
; 20(1): 33-45, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28168377
8.
Management of pasireotide-induced hyperglycemia in patients with acromegaly: An experts' consensus statement.
Front Endocrinol (Lausanne)
; 15: 1348990, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38405148
9.
Growth hormone treatment in aged patients with comorbidities: A systematic review.
Growth Horm IGF Res
; 75: 101584, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489867
10.
Age- and sex-adjusted reference intervals for steroid hormones measured by liquid chromatography-tandem mass spectrometry using a widely available kit.
Endocr Connect
; 13(1)2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37938144
11.
Opposing effects of cannabidiol in patient-derived neuroendocrine tumor, pheochromocytoma/paraganglioma primary cultures.
J Clin Endocrinol Metab
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38605427
12.
Delving into Acromegaly.
J Clin Med
; 12(4)2023 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36836189
13.
Can Growth Hormone Lead to a Faster Recovery from Guillain-Barré Syndrome? Case Report of the First Therapeutic Use in One Patient.
Case Rep Neurol
; 15(1): 163-171, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37901128
14.
A combined top-down and bottom-up LC-HRMS/MS method for the quantification of human growth hormone in plasma and serum.
Growth Horm IGF Res
; 72-73: 101560, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37995539
15.
Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature.
Eur J Endocrinol
; 188(4): 353-365, 2023 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36943306
16.
Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome.
Eur J Endocrinol
; 188(4): 375-384, 2023 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36971260
17.
Insulin receptor substrate-1 and -2 mediate resistance to glucose-induced caspase-3 activation in human neuroblastoma cells.
Biochim Biophys Acta
; 1812(5): 573-80, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21354306
18.
Differences in the Distribution of IGF-I Concentrations Between European and US Populations.
J Endocr Soc
; 6(7): bvac081, 2022 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35673402
19.
Diurnal Salivary Cortisol Profiles in Patients with Cushing's Syndrome.
Exp Clin Endocrinol Diabetes
; 130(7): 434-438, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35038761
20.
Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life.
Eur J Cancer
; 176: 88-99, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198246